
Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs
Keywords: Sarolaner; Isoxazoline; Ctenocephalides felis felis; Ctenocephalides canis; KS1; Oral; Flea; Dog; Dose confirmation